Sectors
IPSC
Century Therapeutics, Inc.
2.03
9 x 1.98
2 x 2.59
bid
ask
+
0.00
0.25%
10:27 AM
timesize
| Ytd | 104.02% | |
| 1y | 312.60% |
1.97
day range
2.04
0.43
52 week range
3.04
| Open | 2.00 | Prev Close | 2.02 | Low | 1.97 | High | 2.04 | Mkt Cap | 367.58M |
| Vol | 88.10K | Avg Vol | 1.16M | EPS | -0.93 | P/E | N/A | Forward P/E | -0.76 |
| Beta | 1.57 | Short Ratio | 4.82 | Inst. Own | 61.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 2.16 | 200-d Avg | 1.91 | 1yr Est | 9.67 |
| Income Statement | |||
| Operating Expenses | 36.53M | ||
| Research and Development Expense | 19.60M | ||
| Selling, General and Administrative Expense | 5.79M | ||
| Operating Income | -36.53M | ||
| Net Income | -34.55M | ||
| Net Income Common Stock | -34.55M | ||
| Net Income Common Stock (USD) | -34.55M | ||
| Consolidated Income | -34.55M | ||
| Earnings per Basic Share | -0.17 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.17 | ||
| Earning Before Interest & Taxes (EBIT) | -34.55M | ||
| Earning Before Interest & Taxes (USD) | -34.55M | ||
| Weighted Average Shares | 205.78M | ||
| Weighted Average Shares Diluted | 205.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 52.00M | ||
| Cash and Equivalents (USD) | 52.00M | ||
| Investments | 147.55M | ||
| Investments Current | 70.07M | ||
| Investments Non-Current | 77.48M | ||
| Current Assets | 124.77M | ||
| Property, Plant & Equipment Net | 48.00M | ||
| Total Assets | 287.01M | ||
| Total Debt | 34.63M | ||
| Current Liabilities | 15.07M | ||
| Debt Non-Current | 34.63M | ||
| Total Liabilities | 54.66M | ||
| Accumulated Retained Earnings (Deficit) | -848.11M | ||
| Accumulated Other Comprehensive Income | -694.00K | ||
| Shareholders Equity | 232.35M | ||
| Shareholders Equity (USD) | 232.35M | ||
| Assets Non-Current | 162.24M | ||
| Total Debt (USD) | 34.63M | ||
| Goodwill and Intangible Assets | 34.20M | ||
| Liabilities Non-Current | 39.59M | ||
| Trade and Non-Trade Payables | 4.82M | ||
| Tax Liabilities | 4.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.02M | ||
| Net Cash Flow from Financing | 311.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.76M | ||
| Capital Expenditure | -635.00K | ||
| Issuance (Purchase) of Equity Shares | 311.00K | ||
| Net Cash Flow from Investing | 17.77M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 18.40M | ||
| Net Cash Flow from Operations | -19.83M | ||
| Share Based Compensation | 1.95M | ||